In accord with ASX requirements, Imagion Biosystems has lodged “Appendix 4C, Quarterly report for entities subject to Listing Rule 4.7B” for the Quarter ended 30 September 2017.
View Appendix 4C for Q3, 2017.
Chairman’s Address to Shareholders and Q&A Session at 2023 Annual General Meeting
Imagion Biosystems’ Chairman’s address to shareholders at the 2023 Annual General Meeting. PDF of the 2023 AGM Presentation Deck Watch the AGM 2023 Q&A Session